Lazard Fintech Acquisition Corp. I and Lazard Healthcare Acquisition Corp. I File Registration Statements for Initial Public Offerings
Lazard Ltd (NYSE: LAZ) announced that Lazard Fintech Acquisition Corp. I (LFTA) and Lazard Healthcare Acquisition Corp. I (LHCA) have filed registration statements with the SEC for proposed initial public offerings of 25,000,000 units each at $10.00 per unit. Each unit consists of one Class A ordinary share and one-fifth of a redeemable warrant. The offerings are distinct and not dependent on one another, with no assurance on completion. Goldman Sachs is the book-running manager for both offerings. The registration statements are pending effectiveness.
- None.
- None.
Lazard Ltd (NYSE: LAZ) announced today that each of Lazard Fintech Acquisition Corp. I (“LFTA”) and Lazard Healthcare Acquisition Corp. I (“LHCA”) have publicly filed registration statements on Form S-1 (the “LFTA Registration Statement” and “LHCA Registration Statement”, respectively) with the U.S. Securities and Exchange Commission (the “SEC”) relating to each of their proposed initial public offerings of 25,000,000 units at a price of
The proposed offering by LFTA is separate from the proposed offering by LHCA, and neither proposed offering is conditioned upon the other. Each offering is subject to market and other conditions, and there can be no assurance as to whether or when any offering may be completed, or as to the actual size or terms of any offering.
LFTA and LHCA are each newly organized blank check companies, incorporated as Cayman Islands exempted companies for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. LFTA believes high growth private companies in the financial technology industry present particularly attractive investment opportunities, though it will not be limited to a particular industry or geographic region in its identification and acquisition of a target company. LHCA believes high growth private companies in the healthcare industry present particularly attractive investment opportunities, though it will not be limited to a particular industry or geographic region in its identification and acquisition of a target company.
Goldman Sachs & Co. LLC is acting as sole book-running manager for both proposed offerings, and Lazard Frères & Co. LLC is acting as financial advisor to both LFTA and LHCA.
The proposed offering by LFTA will be made only by means of an LFTA prospectus, which forms a part of the LFTA Registration Statement. The proposed offering by LHCA will be made only by means of an LHCA prospectus, which forms a part of the LHCA Registration Statement. Copies of the LFTA Registration Statement and the preliminary prospectus included therein relating to the proposed LFTA offering, and copies of the LHCA Registration Statement and the preliminary prospectus included therein relating to the proposed LHCA offering, when available, may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of either prospectus, when available, may be obtained from Goldman Sachs & Co. LLC, 200 West Street, New York, NY 10282, Attn: Prospectus Department, by telephone at 866-471-2526 or by emailing prospectus-ny@ny.email.gs.com.
The LFTA Registration Statement relating to the proposed sale of the LFTA securities has been filed with the SEC but has not yet become effective. The LFTA securities may not be sold nor may offers to buy be accepted prior to the time the LFTA Registration Statement becomes effective. The LHCA Registration Statement relating to the proposed sale of the LHCA securities has been filed with the SEC but has not yet become effective. The LHCA securities may not be sold nor may offers to buy be accepted prior to the time the LHCA Registration Statement becomes effective.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy any of these securities, nor shall there be any sale of any of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.
Cautionary Note Regarding Forward-Looking Statements
This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offerings by LFTA and LHCA. No assurance can be given that either offering discussed above will be completed on the terms described, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the LFTA and LHCA, as applicable, including those set forth in the Risk Factors section of the LFTA Registration Statement and the preliminary prospectus included therein, and the Risk Factors section of the LHCA Registration Statement and the preliminary prospectus included therein, respectively. Copies are available on the SEC’s website at www.sec.gov. Neither LFTA nor LHCA undertakes any obligation to update these statements for revisions or changes after the date of this press release, except as required by law.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210322005217/en/
FAQ
What are the terms of the proposed IPOs for Lazard Fintech Acquisition Corp. I (LFTA) and Lazard Healthcare Acquisition Corp. I (LHCA)?
When will the initial public offerings for LFTA and LHCA take place?
Who is managing the proposed offerings for LFTA and LHCA?
What is the significance of the registration statements filed for LFTA and LHCA?
